Ikerketa proiektua
Evaluation of anti-CD160 antibodies in "in vivo" models.
date_range
Iraupena 2019(e)ko martxoa-(a)k 11-(e)tik 2020(e)ko martxoa-(a)k 10-(e)ra izan da
(12 months)
Ikertzaileak
Mª LUISA DEL
RÍO GONZÁLEZ
Arduraduna
JOSE IGNACIO
RODRÍGUEZ BARBOSA
Arduraduna
(2) proiektuarekin lotutako argitalpenak
Erakutsi urterokoaren araberaArtikulua
-
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression
2023
Frontiers in Immunology
-
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
2022
Translational Research